CClinicalTrials.gg
CompletedNCT00788658EFIUpdated Apr 13, 2016

Cognitive Behaviour Therapy for Patients With IBS

An interventional study of Diet modifications and Cognitive behavioral therapy in Irritable Bowel Syndrome, Constipation and Abdominal Pain, sponsored by Rabin Medical Center. Completed. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2016-04-13.

Sponsored by Rabin Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Irritable bowel syndrome (IBS) affects approximately 10-15% of the adult population. This condition is characterized by abdominal pain, altered bowel habit, abdominal bloating and reduced quality of life. Options for treating IBS include pharmacotherapy, psychotherapy, hypnotherapy and cognitive behavior therapy (CBT). Available data on the effectiveness of CBT in IBS patients in Israel are scarce.

The aim of the present study is to assess effectiveness of CBT as compared with standard therapy for IBS patients in Israel The course of CBT consisted of up to six 40 min sessions, and included education about IBS and techniques to reduce focusing on symptoms and to manage stress.Standard therapy includs life style modifications.

The primary outcome measure was the score on a symptom-severity scale specific to IBS.

Read the detailed description

Symptomatic treatment of patients would not be modified

02

Conditions studied

  • Irritable Bowel Syndrome
  • Constipation
  • Abdominal Pain
  • Depression

Keywords

  • Obstructed constipation
  • Quality of life
03

In context

Irritable Bowel Syndrome

1,062 studies on the registry are indexed under Irritable Bowel Syndrome; 190 are open to participants now.

This study's enrollment of 100 is above the median of 71 across 853 interventional studies indexed under Irritable Bowel Syndrome.

Browse Irritable Bowel Syndrome studies →

Lead sponsor

Rabin Medical Center is the lead sponsor of 385 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18-75
  • IBS

Exclusion criteria

Exclusion Criteria:

  • Malignancy
  • Known psychiatric disorders
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Placebo comparator
    Diet modifications

    Diet consultation and life style modifications for 6 sessions

    Behavioral: Diet modifications

  • Active comparator
    Cognitive therapy

    6 sessions of cognitive behavioral therapy

    Behavioral: Cognitive behavioral therapy

Interventions

  • BehavioralDiet modifications

    Diet consultation

    Also known as: Diet

  • BehavioralCognitive behavioral therapy

    Cognitive behavioral therapy

    Also known as: CBT

06

What researchers measure

Primary outcomes

  1. Symptom score

    Time frame: 3 months

Secondary outcomes

  1. Quality of life assessment

    Time frame: 3 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 13, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00788658
Lead sponsor
Rabin Medical Center
Responsible party
Ram Dickman (MD, Rabin Medical Center) — Principal investigator
First posted
Nov 11, 2008
Start date
Dec 2008
Primary completion
Dec 2010
Completion
Dec 2010
Last update
Apr 13, 2016

Study contacts

Ram Dickman, MD
principal investigator · RMC

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion